Delivery Order SPE2DB20D3303-SPE2DB24FA2AR

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sunosi 150 mg tablets. The contract has a ceiling value of $13,927.84 and a period of performance ending on September 30, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of Sunosi 75 mg tablets, a prescription medication, with a ceiling value of $2,283.30 and a completion date of July 9, 2024. The contract is a firm fixed-price delivery order without a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, a major pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,322.06, is for the delivery of Sunosi 75 mg tablets. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,958.70, is for the delivery of 150 mg Sunosi tablets over the period ending July 31, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of SUNOSI 75 mg tablets, a specialty pharmaceutical product. The completion date for this delivery order is February 1, 2024, and the potential value is $2,456.97. This delivery order is not designated as a set-aside contract....
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Sunosi 150 mg tablets to the government. The firm-fixed-price delivery order, valued at $1,796.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 4, 2024 and was awarded on November 1, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,369.99 firm fixed price contract is for the supply of Sunosi 75 mg tablets to support military healthcare programs. The contract has a period of performance through January 31, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The order, valued at $3,314.95, is for the supply of 75 mg SUNOSI tablets (national stock number 4565618399). The award has a firm fixed price and the ultimate completion date is August 29, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,300.53, is for the delivery of the drug Sunosi (150 mg tablets) and has a completion date of February 28, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This $1,299.54 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 75mg Sunosi tablets to support federal healthcare programs. The award has an ultimate completion date of July 24, 2024 and there is no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts with DLA and other agencies, valued up to $999,999,999 and $750,000 respectively,...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA2AR
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sunosi 75 mg tablets. The fixed-price contract has a ceiling value of $1,664.18 and an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities, including prescription drugs and medical supplies, in support of military treatment programs and facilities worldwide. There is no set-aside designation for this specific delivery order.

Generated 11/12/24, 9:07 AM